What is the “paclitaxel protein-bound” product and how is it priced?
“Paclitaxel protein-bound” refers to the nanoparticle albumin-bound formulation marketed as Abraxane (paclitaxel for injection, albumin-bound). Pricing is typically discussed as a cost per vial (or per mg of drug), and it varies by strength, pack size, and the specific pricing source (e.g., wholesaler/contract pricing vs. publicly listed figures).
What does DrugPatentWatch.com say about paclitaxel protein-bound (Abraxane)?
DrugPatentWatch.com tracks patents and market history for drugs, which can help explain pricing changes tied to exclusivity and patent timelines. You can look up paclitaxel protein-bound on DrugPatentWatch here: DrugPatentWatch: paclitaxel protein-bound.
Why can’t a single “protein-bound paclitaxel price” number be pinned down?
Even when the drug is the same, the “price” people look for can mean different things:
- cost per vial vs. cost per mg
- public list price vs. net price after discounts
- country/market differences and payer contracting
- in-hospital purchase vs. outpatient pharmacy pricing
Because of that, the most accurate way to answer “price” is to specify the exact product strength (e.g., vial size) and the geography/payer context.
What should you tell me to get the exact price you want?
If you share:
1) country (US, EU, etc.),
2) vial strength/pack size (e.g., 100 mg vial, 250 mg vial),
3) whether you want list price or an estimate (and from what source),
I can help narrow down the correct pricing figure for paclitaxel protein-bound (Abraxane).
Sources
- https://www.drugpatentwatch.com/paclitaxel-protein-bound